Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.
Kommoss S, McConechy MK, Kommoss F, Leung S, Bunz A, Magrill J, Britton H, Kommoss F, Grevenkamp F, Karnezis A, Yang W, Lum A, Krämer B, Taran F, Staebler A, Lax S, Brucker SY, Huntsman DG, Gilks CB, McAlpine JN, Talhouk A. Kommoss S, et al. Among authors: lax s. Ann Oncol. 2018 May 1;29(5):1180-1188. doi: 10.1093/annonc/mdy058. Ann Oncol. 2018. PMID: 29432521 Free article.
High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin.
Pohl G, Rudas M, Dietze O, Lax S, Markis E, Pirker R, Zielinski CC, Hausmaninger H, Kubista E, Samonigg H, Jakesz R, Filipits M. Pohl G, et al. Among authors: lax s. J Clin Oncol. 2003 Oct 1;21(19):3594-600. doi: 10.1200/JCO.2003.02.021. J Clin Oncol. 2003. PMID: 14512390
L1CAM: amending the "low-risk" category in endometrial carcinoma.
Kommoss F, Kommoss F, Grevenkamp F, Bunz AK, Taran FA, Fend F, Brucker SY, Wallwiener D, Schönfisch B, Greif K, Lax S, Staebler A, Kommoss S. Kommoss F, et al. Among authors: lax s. J Cancer Res Clin Oncol. 2017 Feb;143(2):255-262. doi: 10.1007/s00432-016-2276-3. Epub 2016 Sep 30. J Cancer Res Clin Oncol. 2017. PMID: 27695947
Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.
Kommoss S, Hartkopf AD, Krämer B, Bunz AK, Grevenkamp F, Kommoss F, Pasternak J, Arbabi SM, Wallwiener M, Staebler A, Lax SF, Brucker SY, Taran FA. Kommoss S, et al. Among authors: lax sf. J Cancer Res Clin Oncol. 2017 Nov;143(11):2183-2188. doi: 10.1007/s00432-017-2474-7. Epub 2017 Jul 14. J Cancer Res Clin Oncol. 2017. PMID: 28710714
302 results